142 related articles for article (PubMed ID: 7511473)
1. Vapreotide, a new somatostatin analogue in the palliative management of obstructive ileus in advanced cancer.
Stiefel F; Morant R
Support Care Cancer; 1993 Jan; 1(1):57-8. PubMed ID: 7511473
[TBL] [Abstract][Full Text] [Related]
2. Treatment of advanced pancreatic cancer with the long-acting somatostatin analogue lanreotide: in vitro and in vivo results.
Raderer M; Hamilton G; Kurtaran A; Valencak J; Haberl I; Hoffmann O; Kornek GV; Vorbeck F; Hejna MH; Virgolini I; Scheithauer W
Br J Cancer; 1999 Feb; 79(3-4):535-7. PubMed ID: 10027326
[TBL] [Abstract][Full Text] [Related]
3. Rapid reversal of life-threatening hypoglycaemia with a somatostatin analogue (octreotide). A case report.
Alberts AS; Falkson G
S Afr Med J; 1988 Jul; 74(2):75-6. PubMed ID: 2899913
[TBL] [Abstract][Full Text] [Related]
4. Somatostatin Analogues Compared With Placebo and Other Pharmacologic Agents in the Management of Symptoms of Inoperable Malignant Bowel Obstruction: A Systematic Review.
Obita GP; Boland EG; Currow DC; Johnson MJ; Boland JW
J Pain Symptom Manage; 2016 Dec; 52(6):901-919.e1. PubMed ID: 27697568
[TBL] [Abstract][Full Text] [Related]
5. Somatostatin analogues in acromegaly and gastroenteropancreatic neuroendocrine tumours: past, present and future.
Öberg K; Lamberts SW
Endocr Relat Cancer; 2016 Dec; 23(12):R551-R566. PubMed ID: 27697899
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of bombesin/gastrin-releasing peptide antagonist RC-3095 and high dose of somatostatin analogue RC-160 on nitrosamine-induced pancreatic cancers in hamsters.
Szepeshazi K; Schally AV; Cai RZ; Radulovic S; Milovanovic S; Szoke B
Cancer Res; 1991 Nov; 51(21):5980-6. PubMed ID: 1682039
[TBL] [Abstract][Full Text] [Related]
7. Role of somatostatins in gastroenteropancreatic neuroendocrine tumor development and therapy.
Oberg KE; Reubi JC; Kwekkeboom DJ; Krenning EP
Gastroenterology; 2010 Sep; 139(3):742-53, 753.e1. PubMed ID: 20637207
[TBL] [Abstract][Full Text] [Related]
8. Clinical and pathophysiological aspects of somatostatin and the gastrointestinal tract.
Lamers CB
Acta Endocrinol Suppl (Copenh); 1987; 286():19-25. PubMed ID: 2892334
[TBL] [Abstract][Full Text] [Related]
9. Somatostatin as adjuvant therapy in the management of obstructive ileus.
Bastounis E; Hadjinikolaou L; Ioannou N; Papastamatiou M; Toumbis E; Makri G
Hepatogastroenterology; 1989 Dec; 36(6):538-9. PubMed ID: 2575572
[TBL] [Abstract][Full Text] [Related]
10. Carcinoid of the pancreas.
Migliori M; Tomassetti P; Lalli S; Casadei R; Santini D; Corinaldesi R; Gullo L
Pancreatology; 2002; 2(2):163-6. PubMed ID: 12123097
[TBL] [Abstract][Full Text] [Related]
11. Escape of the response to a long-acting somatostatin analogue (SMS 201-995) in patients with VIPoma.
Koelz A; Kraenzlin M; Gyr K; Meier V; Bloom SR; Heitz P; Stalder H
Gastroenterology; 1987 Feb; 92(2):527-31. PubMed ID: 2878857
[TBL] [Abstract][Full Text] [Related]
12. Different response to the long-acting somatostatin analogues lanreotide and octreotide in a patient with a malignant carcinoid.
Raderer M; Kurtaran A; Scheithauer W; Fiebiger W; Weinlaender G; Oberhuber G
Oncology; 2001; 60(2):141-5. PubMed ID: 11244329
[TBL] [Abstract][Full Text] [Related]
13. The use of a long-acting somatostatin analogue in the treatment of advanced endocrine malignancies with gastrointestinal symptoms.
Ahlman H; Tisell LE
Scand J Gastroenterol; 1987 Oct; 22(8):938-42. PubMed ID: 2891186
[TBL] [Abstract][Full Text] [Related]
14. [Successful therapy of VIPoma with the long-acting somatostatin analogue SMS 201-995].
Maeda M; Niitsu Y; Goto Y; Kogawa K; Watanabe N; Kohgo Y; Urushizaki I
Nihon Naika Gakkai Zasshi; 1988 Jan; 77(1):86-90. PubMed ID: 2897419
[No Abstract] [Full Text] [Related]
15. Palliation of malignant intestinal obstruction using octreotide.
Khoo D; Hall E; Motson R; Riley J; Denman K; Waxman J
Eur J Cancer; 1994; 30A(1):28-30. PubMed ID: 7511400
[TBL] [Abstract][Full Text] [Related]
16. [Somatostatin analogs in the treatment of pancreatic cancer: utopia or feasible alternative?].
Zalatnai A; Pogány V
Orv Hetil; 2000 Oct; 141(43):2333-8. PubMed ID: 11089387
[TBL] [Abstract][Full Text] [Related]
17. Vapreotide acetate for the treatment of esophageal variceal bleeding.
Calès P
Expert Rev Gastroenterol Hepatol; 2008 Apr; 2(2):185-92. PubMed ID: 19072353
[TBL] [Abstract][Full Text] [Related]
18. The use of somatostatin and its analogs in the treatment of surgical disorders.
Mulvihill S; Pappas TN; Passaro E; Debas HT
Surgery; 1986 Sep; 100(3):467-76. PubMed ID: 2874618
[TBL] [Abstract][Full Text] [Related]
19. The management of gastroenteropancreatic neuroendocrine tumors with somatostatin analogues.
Khagi S; Saif MW
JOP; 2014 Jul; 15(4):295-8. PubMed ID: 25076324
[TBL] [Abstract][Full Text] [Related]
20. Somatostatin analogues in the prevention of pancreas-related complications after pancreatic resection.
Ramos-De la Medina A; Sarr MG
J Hepatobiliary Pancreat Surg; 2006; 13(3):190-3. PubMed ID: 16708293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
